Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Traws Pharma (TRAW) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Traws Pharma (TRAW) over the last 6 years, with Q3 2025 value amounting to $8.8 million.

  • Traws Pharma's Shares Outstanding (Diluted Average) rose 74489.55% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year increase of 74489.55%. This contributed to the annual value of $1.6 million for FY2024, which is 8494.16% up from last year.
  • Latest data reveals that Traws Pharma reported Shares Outstanding (Diluted Average) of $8.8 million as of Q3 2025, which was up 74489.55% from $7.6 million recorded in Q2 2025.
  • In the past 5 years, Traws Pharma's Shares Outstanding (Diluted Average) ranged from a high of $21.0 million in Q2 2023 and a low of $839554.0 during Q4 2023
  • Over the past 5 years, Traws Pharma's median Shares Outstanding (Diluted Average) value was $14.6 million (recorded in 2021), while the average stood at $11.5 million.
  • Per our database at Business Quant, Traws Pharma's Shares Outstanding (Diluted Average) plummeted by 9598.46% in 2023 and then surged by 75716.99% in 2025.
  • Over the past 5 years, Traws Pharma's Shares Outstanding (Diluted Average) (Quarter) stood at $16.8 million in 2021, then rose by 24.22% to $20.9 million in 2022, then crashed by 95.98% to $839554.0 in 2023, then skyrocketed by 84.94% to $1.6 million in 2024, then soared by 467.97% to $8.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $8.8 million in Q3 2025, compared to $7.6 million in Q2 2025 and $7.2 million in Q1 2025.